Aprepitant
Overview
Categories
- 17 Gastrointestinal drugs
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Aprepitant's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 80 to 125 mg | 100 (102.5) | As recommended. | PO | Aprepitant is given for 3 days as part of a regimen that includes a corticosteroid and a 5-HT3 antagonis for moderate to highly emetogenic cancer chemotherapy:. The recommended dose of aprepitant is 125 mg orally 1 hour prior to chemotherapy treatment (Day 1) and 80 mg orally once daily in the morning on Days 2 and 3.
It may be taken with or with out food. |
| 40 to 40 mg | 40 (40) | As recommended. | PO | For prevention of postoperative nausea and vomiting (PONV): The recommended oral dosage of aprepitant is 40 mg within 3 hours prior to induction of anesthesia. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Aprepitant is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Aprepitant is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Aprepitant
Back to top
Previous Drug Generic - Next Drug Generic